Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940

Is a “Cytokine Storm” Relevant to COVID-19?

Sinha, P., Matthay, M. A., & Calfee, C. S. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3313 · Cited by 724

Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers

Khan, S. S., Smith, M. S., Reda, D., Suffredini, A. F., & McCoy, J. P. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20021 · Cited by 357

Cytometry

Özgen, Ü., Savaşan, S., Buck, S. A., & Ravindranath, Y. (2010) · Cytometry · doi:10.1002/(issn)1097-0320 · Cited by 211

Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients

Timmermans, K., Kox, M., Vaneker, M., van den Berg, M. P., John, A. T., van Laarhoven, A., van der Hoeven, H., Scheffer, G. J., & Pickkers, P. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4205-3 · Cited by 184

Norepinephrine Contributes to Enterocyte Damage in Septic Shock Patients: A Prospective Cohort Study

Habes, Q. L. M., van Ede, L., Gerretsen, J., Kox, M., & Pickkers, P. (2017) · Shock · doi:10.1097/shk.0000000000000955 · Cited by 31

The Involvement of Danger-Associated Molecular Patterns in the Development of Immunoparalysis in Cardiac Arrest Patients

Timmermans, K., Kox, M., Gerretsen, J., Peters, E., Scheffer, G. J., van der Hoeven, J. G., Pickkers, P., & Hoedemaekers, C. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001204 · Cited by 30

Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery

Arsentieva, N. A., Liubimova, N. E., Batsunov, O. K., Korobova, Z. R., Stanevich, O. V., Lebedeva, A. A., Vorobyov, E. A., Vorobyeva, S. V., Куликов, А. Н., Lioznov, D. A., et al. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pci-2312 · Cited by 33

Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’

Smieszek, S. P., Przychodzen, B. P., Polymeropoulos, V. M., Polymeropoulos, C. M., & Polymeropoulos, M. H. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155662 · Cited by 33

“Acute Myocardial Infarction in the Time of COVID-19”: A Review of Biological, Environmental, and Psychosocial Contributors

Gorini, F., Chatzianagnostou, K., Mazzone, A., Bustaffa, E., Esposito, A., Berti, S. L., Bianchi, F., & Vassalle, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207371 · Cited by 31

Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs

Boutin, S., Hildebrand, D., Boulant, S., Kreuter, M., Rüter, J., Pallerla, S. R., Velavan, T. P., & Nurjadi, D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03889-5 · Cited by 32

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

Rodríguez-Hernández, M. Á., Carneros, D., Núñez‐Núñez, M., Zuñiga, R. C., Baena, R., López-Ruiz, G. M., Cano-Serrano, M. E., Martínez-Tellería, A., Fuentes, A. P., Praena‐Fernández, J. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891456 · Cited by 31

OUP accepted manuscript

Pribić, T., Alves, I., Bugada, D., Pascual, J., Vučković, F., Skelin, A., Gaifem, J., Villar-García, J., Vicente, M. M., Fernandes, Â., et al. (2020) · Glycobiology · doi:10.1093/glycob/cwaa102 · Cited by 30

Cardiovascular aspects of COVID-19

Kurz, D. J., & Eberli, F. R. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20417 · Cited by 33

Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis

Dong, X., Wang, C., Liu, X., Gao, W., Bai, X., & Li, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.598404 · Cited by 27

The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences

Ruiz‐Rodríguez, J. C., Molnár, Z., Deliargyris, E., & Ferrer, R. (2021) · Critical Care Research and Practice · doi:10.1155/2021/7769516 · Cited by 29

Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic

Iba, T., Levy, J. H., & Levi, M. M. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1562-7599 · Cited by 29

Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection

Marteles, M. S., Rubio‐Gracia, J., Peña‐Fresneda, N., Garcés‐Horna, V., Gracia-Tello, B., Martínez‐Lostao, L., Crespo-Aznárez, S., Pérez‐Calvo, J. I., & Gimenez-Lopez, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163534 · Cited by 29

New Decade, Old Debate: Blocking the Cytokine Pathways in Infection-Induced Cytokine Cascade

Rizvi, M. S., & de Moraes, A. G. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000364 · Cited by 27

Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial

Jarczak, D., Roedl, K., Fischer, M., de Heer, G., Burdelski, C. M., Frings, D. P., Sensen, B., Boenisch, O., Tariparast, P. A., Kluge, S., et al. (2022) · Blood Purification · doi:10.1159/000526446 · Cited by 29

Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19

Sun, C., Jan, J., Wang, I.-H., Ma, H., Ko, H., Wu, P., Kuo, T.-J., Liao, H.-N., Lan, Y.-H., Sie, Z., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009758 · Cited by 28

Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness

Morrell, E. D., Bhatraju, P. K., Sathe, N. A., Lawson, J. J., Mabrey, L., Holton, S. E., Presnell, S., WIEDEMAN, A. E., Acosta‐Vega, C., Mitchem, M. A., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00049.2022 · Cited by 26

During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant

Cavaillon, J. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08965-1 · Cited by 26

Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19

Grant, R. A., Poor, T. A., Sichizya, L., Diaz, E., Bailey, J. I., Soni, S., Senkow, K. J., Pérez-Leonor, X. G., Abdala‐Valencia, H., Lu, Z., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.178859 · Cited by 27

Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

Qu, W., Wang, Z., Engelberg-Cook, E., Yan, D., Siddik, A. B., Bu, G., Allickson, J. G., Kubrova, E., Caplan, A. I., Hare, J. M., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac032 · Cited by 26

Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning

Porter, N. S., & Jason, L. A. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s379653 · Cited by 24

Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?

Zahra, A., Sisu, C., Silva, E. A., Greca, S.-C. D. A., Randeva, H. S., Chatha, K. K., Kyrou, I., & Karteris, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103296 · Cited by 23

Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns

Christensen, E. E., Jørgensen, M. J., Nore, K. G., Dahl, T. B., Yang, K., Ranheim, T., Huse, C., Lind, A., Nur, S., Stiksrud, B., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13310 · Cited by 23

Factors associated with mortality in patients hospitalized with COVID-19: A prospective cohort in a Peruvian national referral hospital

Vences, M. A., Pareja-Ramos, J. J., Otero, P., Veramendi-Espinoza, L. E., Vega-Villafana, M., Mogollón-Lavi, J., Morales, E., Olivera-Vera, J., Meza, C., Salas-Lazo, L. J., et al. (2021) · Medwave · doi:10.5867/medwave.2021.06.8231 · Cited by 23

Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

Bermejo-Martín, J. F., García‐Mateo, N., Motos, A., Resino, S., Tamayo, L., Ryan, P., Bustamante‐Munguira, E., Curto, E. G., Úbeda, A., de la Torre, M. D. C., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00041-1 · Cited by 23

Cytokine “storm”, cytokine “breeze”, or both in COVID-19?

Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1761 · Cited by 24

Dysregulation of Human Hepatic Drug Transporters by Proinflammatory Cytokines

Hao, T., Tsang, Y. P., Yin, M., Mao, Q., & Unadkat, J. D. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002019 · Cited by 21

Kidney injury in COVID-19

Ahmed, A. R., Ebad, C. A., Stoneman, S., Satti, M. M., & Conlon, P. J. (2020) · World Journal of Nephrology · doi:10.5527/wjn.v9.i2.18 · Cited by 25

COVID-19

Ashraf, O., Virani, A., & Cheema, T. J. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000346 · Cited by 24

Platelet Function in Viral Immunity and SARS-CoV-2 Infection

Allaoui, A., Khawaja, A. A., Badad, O., Naciri, M., Lordkipanidzé, M., Guessous, F., & Zaid, Y. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1726033 · Cited by 22

Hepcidin Increases Cytokines in Alzheimer’s Disease and Down’s Syndrome Dementia: Implication of Impaired Iron Homeostasis in Neuroinflammation

Raha, A. A., Ghaffari, S. D., Henderson, J. W., Chakraborty, S., Allinson, K. S. J., Friedland, R. P., Holland, A. J., Zaman, S. H., Mukaetova-Ladinska, E. B., & Raha‐Chowdhury, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653591 · Cited by 21

Secondary pneumonias in critically ill patients with COVID-19: risk factors and outcomes

Póvoa, P. M. S. R., Martín‐Loeches, I., & Nseir, S. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000860 · Cited by 24

In-Depth Investigation of Conjunctival Swabs and Tear Fluid of Symptomatic COVID-19 Patients, an Observational Cohort Study

Gijs, M., Veugen, J. M. J., Wolffs, P. F. G., Savelkoul, P. H. M., Tas, J., van Bussel, B. C. T., de Kruif, M. D., Henry, R. M. A., Webers, C. A. B., Dickman, M. M., et al. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.12.32 · Cited by 22

Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection

Li, W., Syed, F., Yu, R., Yang, J., Xia, Y., Relich, R. F., Russell, P. M., Zhang, S., Khalili, M., Huang, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833310 · Cited by 23

SARS-CoV-2-Infection (COVID-19): Clinical Course, Viral Acute Respiratory Distress Syndrome (ARDS) and Cause(s) of Death

Ramadori, G. P. (2022) · Medical Sciences · doi:10.3390/medsci10040058 · Cited by 24

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death

Székely, L., Bozóky, B., Béndek, M., Ostad, M., Lavignasse, P., Haag, L., Wu, J., Xu, J., Gupta, S., Saccon, E., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07134 · Cited by 23

The Impacts of COVID-19 on Musculoskeletal Health

Awosanya, O. D., Dadwal, U. C., Imel, E. A., Yu, Q., & Kacena, M. A. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00734-x · Cited by 22

The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox

Balík, M., Svobodová, E., Pořízka, M., Malý, M., Brestovansky, P., Volny, L., Brožek, T., Bartosova, T., Jurisinova, I., Mevaldova, Z., et al. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154162 · Cited by 21

Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms

An, A. Y., Baghela, A. S., Zhang, P. G. Y., Falsafi, R., Lee, A. H., Trahtemberg, U., BAKER, A. J., dos Santos, C. C., & Hancock, R. E. W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1167917 · Cited by 20

Investigational pharmacological agents for the treatment of ARDS

Aribindi, K., Lim, M., Lakshminrusimha, S., & Albertson, T. E. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2315128 · Cited by 22

IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid

Donoso-Navarro, E., Arribas, I., & Bernabéu-Andréu, F. A. (2021) · Biomarker Insights · doi:10.1177/11772719211013363 · Cited by 20

Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling

Rossi, J., Chiang, H.-C., Lu, Z., Levón, K., van Rhee, F., Kanhai, K. J. K., Fajgenbaum, D. C., & Klein, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919489 · Cited by 20

Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters

Rössler, T., Berezhnoy, G., Singh, Y., Cannet, C., Reinsperger, T., Schäfer, H., Spraul, M., Kneilling, M., Merle, U., & Trautwein, C. (2022) · Metabolites · doi:10.3390/metabo12121277 · Cited by 19

Clinical features and outcomes of COVID ‐19 in patients with solid tumors: Turkish National Registry Data

Özdemir, N., Dızdar, Ö., Yazıcı, O., Aksoy, S., Dede, D. Ş., Budakoğlu, B., Metan, G., Alp, A., Budakoğlu, I. İ., Öksüzoğlu, B. Ç., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33426 · Cited by 20

Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study

Gharamti, A. A., Mei, F., Jankousky, K. C., Huang, J., Hyson, P. R., Chastain, D. B., Fan, J., Osae, S. P., Zhang, W. W., Montoya, J. G., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab124 · Cited by 20

Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study

Dechamps, M., Poortere, J. D., Martin, M., Gatto, L., Daumerie, A., Bouzin, C., Octave, M., Ginion, A., Robaux, V., Pirotton, L., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.780750 · Cited by 20

Composition of the immunoglobulin G glycome associates with the severity of COVID-19Preprint

Petrović, T., Alves, I., Bugada, D., Pascual, J., Vučković, F., Skelin, A., Gaifem, J., Villar-García, J., Vicente, M. M., Fernandes, Â., et al. (2020) · medRxiv · doi:10.1101/2020.10.17.20214205 · Cited by 20

Early Clinical and Electrophysiological Brain Dysfunction Is Associated With ICU Outcomes in COVID-19 Critically Ill Patients With Acute Respiratory Distress Syndrome: A Prospective Bicentric Observational Study*

Benghanem, S., Cariou, A., Diehl, J., Marchi, A., Charpentier, J., Augy, J.-L., Hauw‐Berlemont, C., Gavaret, M., Pène, F., Mira, J. P., et al. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005491 · Cited by 21

CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis

Wei, S., Zhang, Y., Zhai, K., Li, J., Li, M., Yang, J., Zhang, R., Li, Y., & Li, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1067214 · Cited by 18

COVID-19 Acute Respiratory Distress Syndrome

Empson, S., Rogers, A. J., & Wilson, J. G. (2022) · Critical Care Clinics · doi:10.1016/j.ccc.2022.02.001 · Cited by 20

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection

Gambichler, T., Reuther, J., Scheel, C., Susok, L., Kern, P., & Becker, J. C. (2020) · Cancers · doi:10.3390/cancers12113383 · Cited by 19

Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19

Udovičić, I., Stanojević, I., Djordjevic, D., Zeba, S., Rondović, G., Abazovic, T., Lazic, S., Vojvodić, D., To, K., Abazović, D., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245815 · Cited by 19

Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients

Eichhorn, T., Huber, S., Weiss, R., Ebeyer-Masotta, M., Lauková, L., Emprechtinger, R., Bellmann‐Weiler, R., Lorenz, I. H., Martini, J., Pirklbauer, M., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13061069 · Cited by 17

Coronavirus Disease 2019 Calls for Predictive Analytics Monitoring—A New Kind of Illness Scoring System

Davis, J. P., Wessells, D. A., & Moorman, J. R. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000294 · Cited by 17

COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17

Predictive value of specific cytokines for lethal COVID-19 outcome

Arsentieva, N. A., Liubimova, N. E., Batsunov, O. K., Korobova, Z. R., Kuznetsova, R. N., Rubinstein, A., Stanevich, O. V., Lebedeva, A. A., Vorobyev, E. A., Vorobieva, S. V., et al. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-pvo-2043 · Cited by 17

Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption

Ruiz‐Rodríguez, J. C., Plata-Menchaca, E. P., Chiscano‐Camón, L., Ruiz‐Sanmartín, A., & Ferrer, R. (2022) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-022-00043-w · Cited by 16

Subtle vascular and astrocytic changes in the brain of coronavirus disease 2019 ( COVID ‐19) patients

Roşu, G. C., Mateescu, V. O., Simionescu, A., Istrate-Ofiţeru, A.-M., Curcă, G. C., Pirici, I., Mogoantă, L., Mîndrilă, I., Kumar‐Singh, S., Hostiuc, S., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15545 · Cited by 15

Application of extracorporeal therapies in critically ill COVID-19 patients

Zhou, Z., Kuang, H., Ma, Y., & Zhang, L. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100344 · Cited by 16

Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID‐19

Zhou, Z., Zhou, X. P., Cheng, L., Wen, L., An, T., Gao, H., Deng, H., Qi, Y., Zhang, X., Li, Y., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.523 · Cited by 15

Cardiac complications in patients with COVID-19: a systematic review

Brogi, E., Marino, F. V., Bertini, P., Tavazzi, G., Corradi, F., & Forfori, F. (2022) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-022-00046-7 · Cited by 16

Circulating pentraxin 3 in severe COVID‐19 or other pulmonary sepsis

Protti, A., Meessen, J. M. T. A., Bottazzi, B., Garlanda, C., Milani, A., Bacci, M., Mantovani, A., Cecconi, M., Latini, R., & Caironi, P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13530 · Cited by 14

Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?

Palacios, Y., & Chávez‐Galán, L. (2022) · Pharmaceuticals · doi:10.3390/ph15050616 · Cited by 15

Acute SARS-CoV-2 infection

Sherman, A. C., Gray, G., Cao, B., To, K. K., Rouphael, N., Restrepo, A. M. H., Gordon, A. C., & Baden, L. R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00662-x · Cited by 19

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

Copaescu, A. M., James, F., Mouhtouris, E., Vogrin, S., Smibert, O. C., Gordon, C. L., Drewett, G. P., Holmes, N. E., & Trubiano, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.646095 · Cited by 14

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study

Oblitas, C., Valle, F. G., Ramírez-Navarro, J., López-Cano, J., Monterrubio-Manrique, Á., García‐Gámiz, M., Sancho-González, M., Arenal-López, S., Walther, L. A. Á.-S., & Rodríguez, P. D. (2021) · Viruses · doi:10.3390/v13122445 · Cited by 14

Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials

Wu, Q., Pennini, M. E., Bergmann, J. N., Kozak, M., Herring, K. D., Sciarretta, K. L., & Armstrong, K. L. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac381 · Cited by 14

Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia

Ruiz‐Rodríguez, J. C., Chiscano‐Camón, L., Ruiz‐Sanmartín, A., Palmada, C., Plata-Menchaca, E. P., Franco‐Jarava, C., Pérez-Carrasco, M., Hernández-González, M., & Ferrer, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.779038 · Cited by 14

From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?

Rondović, G., Djordjevic, D., Udovičić, I., Stanojević, I., Zeba, S., Abazovic, T., Vojvodić, D., Abazović, D., Khan, W. S., & Šurbatović, M. (2022) · Biomedicines · doi:10.3390/biomedicines10102620 · Cited by 14

Essential fatty acids and their metabolites in the pathobiology of (coronavirus disease 2019) COVID-19

Das, U. N. (2020) · Nutrition · doi:10.1016/j.nut.2020.111052 · Cited by 13

The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury

Lippi, G., Szergyuk, I., de Oliveira, M. H. S., Benoit, S. W., Benoit, J. L., Favaloro, E. J., & Henry, B. M. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02597-y · Cited by 13

Immunologic response in bacterial sepsis is different from that in COVID-19 sepsis

Perschinka, F., Mayerhöfer, T., Lehner, G. F., Haßlacher, J., Klein, S., & Joannidis, M. (2022) · Infection · doi:10.1007/s15010-022-01803-0 · Cited by 13

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial

Temesgen, Z., Kelley, C. F., Cerasoli, F., Kilcoyne, A., Chappell, D. B., Durrant, C., Ahmed, O., Chappell, G., Catterson, V. M., Polk, C. M., et al. (2022) · Thorax · doi:10.1136/thoraxjnl-2022-218744 · Cited by 13

Sarilumab treatment of hospitalised patients with severe or critical COVID-19: a multinational, randomised, adaptive, phase 3, double-blind, placebo-controlled trialPreprint

Lescure, F.-X., Honda, H., Fowler, R., Lazar, J. S., Shi, G., Wung, P. K., Patel, N. R., & HAGINO, O. R. (2021) · medRxiv · doi:10.1101/2021.02.01.21250769 · Cited by 13

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune

Timofeeva, A. M., Sedykh, S. E., Ermakov, E. A., Matveev, A. L., Odegova, E. I., Sedykh, T. A., Щербаков, Д. Н., Merkuleva, I. A., Volosnikova, E. A., Nesmeyanova, V. S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213681 · Cited by 12

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?

Plocque, A., Mitri, C., Lefèvre, C., Tabary, O., Touqui, L., & Philippart, F. (2022) · Drugs · doi:10.1007/s40265-022-01803-2 · Cited by 12

Treatment With Tocilizumab for Patients With COVID‐19 Infections: A Case‐Series Study

Mo, Y., Adarkwah, O., Zeibeq, J., Pinelis, E., Orsini, J., & Gasperino, J. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1787 · Cited by 12

Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression

Al-Otaibi, T., Gheith, O. A. A., Abuelmagd, M. M., Adel, M., Alqallaf, A. K. E. A., Elserwy, N., Shaker, M., Abbas, A. M., Nagib, A. M., Nair, P. M., et al. (2021) · Clinical Transplantation · doi:10.1111/ctr.14297 · Cited by 11

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients

Zhang, M., Yao, X., Hou, Z., Guo, X., Tu, S., Lei, Z., Yu, Z., Liu, X., Cui, C., Chen, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585021 · Cited by 13

Zoonotic coronavirus epidemics

Fung, M., Otani, I. M., Pham, M. N., & Babik, J. M. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.11.021 · Cited by 16

Precision Medicine in Acute Respiratory Distress Syndrome

Leonard, J. M., & Sinha, P. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.08.005 · Cited by 12

Antivirális és gyulladásellenes kezelési lehetőségek COVID–19-ben

Szekanecz, Z., Bogos, K., Constantin, T., Fülesdi, B., Müller, V., Rákóczi, É., Várkonyi, I. Z., & Valyi-Nagy, I. T. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32230 · Cited by 11

Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection

Lee, A. J., Feng, E., Chew, M. V., Balint, E., Poznanski, S. M., Giles, E. C., Zhang, A., Marzok, A., Revill, S. D., Vahedi, F., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010471 · Cited by 11

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

Shi, L., Zheng, Y. Y., Cheng, Z., Ji, N., Niu, C., Wang, Y., Huang, T., Li, R., Huang, M., Chen, X., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02972-3 · Cited by 11

Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State

Limmer, A., Engler, A., Kattner, S., Gregorius, J., Pattberg, K., Schulz, R., Schwab, J., Roth, J., Vogl, T., Krawczyk, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11020435 · Cited by 10

The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19

Zhi, J., Zhao, K., Liu, J., Yang, D. L., Deng, X., Xu, J., & Zhang, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1447403 · Cited by 10

Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09

Hernández‐Cardenas, C. M., Lugo-Goytia, G., Hernández-García, D. A., & Pérez‐Padilla, R. (2021) · Medicina Intensiva · doi:10.1016/j.medin.2021.05.014 · Cited by 10

Low‐dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID‐19 pneumonia

Çelik, İ., EREN, E. E., Toker, A. K., Eren, D., Yıldız, M., Kanat, A., Topaloğlu, U. S., Güzeldağ, S., Kara, M., & Ulu-Kılıç, A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14997 · Cited by 9

Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in Colombia

Molina, F. J., Botero, L. E., Isaza, J. P., Cano, L. E., López, L., Palacio, L. M. H., Correa, E., & Torres, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1005636 · Cited by 9

Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients

Gibot, S., Lafon, T., Jacquin, L., Lefèvre, B., Kimmoun, A., Guillaumot, A., Losser, M.-R., Douplat, M., Argaud, L., Ciancio, G. D., et al. (2023) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00532-4 · Cited by 9

Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Patoulias, D., Papadopoulos, C. E., Katsimardou, A., Toumpourleka, M., & Doumas, M. N. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00942-7 · Cited by 9

The COVID‐19 Menace

Walczak, P., & Janowski, M. (2021) · Global Challenges · doi:10.1002/gch2.202100004 · Cited by 9

Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?

Valyi-Nagy, I. T., Uher, F., Rákóczi, É., & Szekanecz, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213951 · Cited by 9

Efficacy of the Cytokine Adsorption Therapy in Patients with Severe COVID-19-Associated Pneumonia: Lesson Learned from a Prospective Observational Study

Kusirisin, P., Noppakun, K., Trongtrakul, K., Vongsanim, S., Suteeka, Y., Ophascharoensuk, V., Pongsuwan, K., Narongkiatikhun, P., Theerakittikul, T., Apaijai, N., et al. (2023) · Blood Purification · doi:10.1159/000534914 · Cited by 9

Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19

Alberts, R., Chan, S. C. L., Meng, Q., He, S., Rao, L., Liu, X., & Zhang, Y. (2022) · Immune Network · doi:10.4110/in.2022.22.e22 · Cited by 8

Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study

Rahmoun, M. A., Elabbadi, A., Guillemot, D., Brun‐Buisson, C., & Watier, L. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11000-7 · Cited by 8

Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients

Adamik, B., Ambrożek-Latecka, M., Dragan, B., Jeznach, A., Śmiechowicz, J., Goździk, W., & Skirecki, T. (2022) · Shock · doi:10.1097/shk.0000000000001923 · Cited by 8

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

Shetty, A. K., Shetty, P. A., Zanirati, G., & Jin, K. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00161-z · Cited by 8

Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases

Kaur, H., Bawaskar, R. S., Khobragade, A. A. K., Kalra, D., Packiam, V., Khan, M. Y., Bhogal, T. K., Sharma, M., Verma, N. K., Kaushik, S., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292783 · Cited by 8

Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus

Coloretti, I., Berlot, G., Busani, S., Rosa, F. G. D., Donati, A., Forfori, F., Grasselli, G., Mirabella, L., Tascini, C., Viale, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163500 · Cited by 9

Extracellular matrix turnover in severe COVID-19 is reduced by corticosteroids

Pillay, J., Flikweert, A. W., van Meurs, M., Grootenboers, M., der Brugge, S. V. D. S., van der Voort, P. H. J., Karsdal, M. A., Sand, J. M. B., Leeming, D. J., Burgess, J. K., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03098-9 · Cited by 8

Critical appraisal of the “cytokine storm” concept in new coronavirus disease COVID-19. Review

Bobkova, S. S., Zhukov, A. A., Николаевич, П. Д., Samoylenko, V. V., & Tyurin, I. N. (2021) · Annals of critical care · doi:10.21320/1818-474x-2021-1-57-68 · Cited by 8

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Leisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V. V., Mastroianni, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 874

Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19

Vassiliou, A. G., Dimopoulou, I., Jahaj, E., Keskinidou, C., Mastora, Z., Orfanos, S. E., & Kotanidou, Α. (2021) · In Vivo · doi:10.21873/invivo.12381 · Cited by 4

Covid-19 and Cytokine Storm

Vergara, L. L., Torralba, L., Diego, C. D., Lasierra, A., Lahoz, R., Abadía, C., de Gopegui, P. R., Godino, J., Cebollada, A., Jimeno, B., et al. (2022) · 10.01 - Respiratory infections and bronchiectasis · doi:10.1183/13993003.congress-2022.3255

COVID 19: in the eye of the cytokine storm

Liuzzo, G., & Patrono, C. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1005 · Cited by 32

Drastically elevated levels of Interleukin-6 and its soluble receptor complex in COVID-19 patients with acute respiratory distress

Spigna, G. D., Cernia, D. S., Vargas, M., Buonavolontà, L., Servillo, G., & Postiglione, L. (2020) · Clinical and Medical Investigations · doi:10.15761/cmi.1000211 · Cited by 15